| NCT ID | NCT05487131 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oklahoma |
| Condition | Healthy Aging |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2023-06-03 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2023-06-03 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this project, we aim to determine any potential effects of a weak electrical current applied to the neck or thoracic area on functional capacity and muscle activation. Healthy individuals will participate in one familiarization followed by up to 6 experimental sessions. Fatigability and motor function will be assessed in each test session.
Eligibility Criteria
Inclusion Criteria: Healthy individuals between 18 and 50 years old Exclusion Criteria: Metal implants or joint replacement. Presence of neuromuscular disease. Skin hypersensitivity.
Contact & Investigator
Hugo Pereira, PhD
PRINCIPAL INVESTIGATOR
University of Oklahoma
Frequently Asked Questions
Who can join the NCT05487131 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Healthy Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05487131 currently recruiting?
Yes, NCT05487131 is actively recruiting participants. Contact the research team at hugomax@ou.edu for enrollment information.
Where is the NCT05487131 trial being conducted?
This trial is being conducted at Norman, United States.
Who is sponsoring the NCT05487131 clinical trial?
NCT05487131 is sponsored by University of Oklahoma. The principal investigator is Hugo Pereira, PhD at University of Oklahoma. The trial plans to enroll 40 participants.